Serine/threonine-protein kinase PAK 2
| GO Term |
|---|
| nucleus |
| cell-cell junction |
| membrane |
| secretory granule |
| cytosol |
| perinuclear region of cytoplasm |
| postsynaptic density |
| glutamatergic synapse |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 110 |
|
|
| Pathway Name | Organism |
|---|---|
| CD209 (DC-SIGN) signaling | Mus musculus |
| CD28 dependent Vav1 pathway | Mus musculus |
| Ephrin signaling | Mus musculus |
| FCERI mediated MAPK activation | Mus musculus |
| Generation of second messenger molecules | Mus musculus |
| MAPK6/MAPK4 signaling | Mus musculus |
| RAC1 GTPase cycle | Mus musculus |
| RAC2 GTPase cycle | Mus musculus |
| RAC3 GTPase cycle | Mus musculus |
| RHO GTPases activate PAKs | Mus musculus |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0060041 | autism spectrum disorder |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025